NewsSource: EClinCloud

EClinCloud Product Overview | EDC · Clinical Trial Electronic Data Capture System

2 min readEClinCloud Editorial Team
EClinCloud Product Overview | EDC · Clinical Trial Electronic Data Capture System news header image

Source: EClinCloud. Author: EClinCloud.


EClinCloud EDC (Electronic Data Capture) is a next-generation electronic data capture system for clinical trials. Combining the strengths of multiple international EDC systems with the usage habits of domestic and international users, it provides organizations with an integrated cloud service solution for electronic and intelligent clinical trial data capture, remote data review, and transparent data standards. By adopting this system—upholding ALCOA+ good data standards for clinical trial data capture alongside cutting-edge AI technologies—it helps organizations significantly improve clinical trial data management efficiency and effectively shorten clinical research cycles.


computer-ai.png

AI-Driven One-Stop Product + Service Solution


🔍 What Does EClinCloud Offer?

◉ EDC System

◉ Study Build Services

◉ System Operation Training and Qualification Certification

◉ RAG Parsing Large Model: Customized OCR Recognition to Assist Data Capture



💻 EClinCloud EDC System Features




◉ Efficient, intuitive study build that supports complex clinical trial visit and form design, with low-code configuration of complex edit checks (ECs)

◉ Intelligent data capture and quality control, with AI-assisted data capture to safeguard quality and improve efficiency

◉ Multidimensional data presentation, offering multiple BI solutions including study progress, data cleaning, KRI dashboards, and medical dashboards

◉ Interoperability across systems through standard interface configuration and field-level mapping



💡 Why Choose EClinCloud EDC?


❖ AI-enabled functional modules accelerate improvements in project efficiency

❖ Data-driven design patterns help elevate project quality

❖ Intuitive user interface and straightforward configuration effectively lower the learning curve

❖ Ensures rigorously verified security during database change operations, improving data management flexibility and reliability

❖ Ensures strict data access control and granular user action authorization, and provides SOP system certification to strengthen data protection






About EClinCloud


EClinCloud is a leading AI company in the clinical research industry, leveraging AI to build an integrated clinical intelligence cloud platform and endpoint assessment technologies. It provides global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, alongside scale management, linguistic validation, rater training, and data quality analysis services to deliver efficient, precise digital solutions. Backed by AI predictive models and an intelligent data platform, EClinCloud dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug and device development cycles for the benefit of patients.







Article illustration





Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.